Despite negative reviews, Venom was a hit in 2018. Grossing $856 million at the worldwide box office on a reported $116 million production budget, the movie's success continued when it hit ...

Artificial intelligence could take the bite out of snake venom. Using AI, scientists have designed proteins that say not so fassst to toxins wielded by cobras and other venomous snakes.

The final arc of the Venom trilogy has arrived. Well, assuming Tom Hardy is able to resist returning the role. We may have given the newest addition to the Sony Spider-man timeline a 4/10 in our ...

Snake venom includes a complicated mix of toxins, most of them proteins, that engage in a multi-front assault on anything unfortunate enough to get bitten. Right now, the primary treatment is to ...

Just when his life is at its lowest, he becomes host to an alien symbiote which results in extraordinary superpowers — transforming him into the brain-munching Venom. The lethal protector must ...

Researchers have successfully designed two proteins to neutralize some of the most lethal venom toxins, using a suite of artificial intelligence tools, per a study published January 15 in the ...

April’s Web of Venomverse: Fresh Brains #1 features a new Eddie Brock Venom (whose 616 counterpart will debut as Carnage in Eddie Brock: Carnage in February), Venomouse, and a venomized Katie ...

A larger and more venomous species of one of the world's deadliest spiders has been confirmed by Australian scientists. Nicknamed 'big boy', it can grow up to 9cm (3.54 inches) compared with 5cm ...

In a report released today, Callum Elliott from Bernstein maintained a Buy rating on Unilever (ULVR – Research Report), with a price target of £52.00. The company’s shares opened today at p4 ...

For the first time in almost 20 years, Walmart has a new logo. The international retailer describes it as a “a comprehensive brand refresh,” but the online world hasn’t been quite so kind to ...

Hindustan Unilever has agreed to acquire beauty startup Minimalist for about $342 million, as the consumer goods giant seeks to expand in India’s fast-growing premium skincare market.

UBS analyst Guillaume Delmas maintained a Sell rating on Unilever (ULVR – Research Report) today and set a price target of £40.50. The company’s shares opened today at p4,595.00. Leverage the ...